<p>lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma

Published:2019-04 Issue: Volume:Volume 11 Page:3813-3828
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Wang Fan,Qi Xun,Li Zixuan,Jin Shiqi,Xie Yang,Zhong Hongshan

Publisher

Informa UK Limited

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression;Pathology - Research and Practice;2024-06

2. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives;Pathology - Research and Practice;2024-06

3. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition;International Journal of Molecular Sciences;2023-05-18

4. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-05-17

5. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets;Progress in Biophysics and Molecular Biology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP